199 related articles for article (PubMed ID: 2992369)
1. Comparison of the in vitro and in vivo antiherpes virus activities of the acyclic nucleosides, acyclovir (Zovirax) and 9-[(2-hydroxy-1-hydroxymethylethoxy)methyl]guanine (BWB759U).
Collins P; Oliver NM
Antiviral Res; 1985 Jun; 5(3):145-56. PubMed ID: 2992369
[TBL] [Abstract][Full Text] [Related]
2. The spectrum of antiviral activities of acyclovir in vitro and in vivo.
Collins P
J Antimicrob Chemother; 1983 Sep; 12 Suppl B():19-27. PubMed ID: 6313598
[TBL] [Abstract][Full Text] [Related]
3. Comparison of a DNA probe assay with the plaque reduction assay for measuring the sensitivity of herpes simplex virus and varicella-zoster virus to penciclovir and acyclovir.
Standring-Cox R; Bacon TH; Howard BA
J Virol Methods; 1996 Jan; 56(1):3-11. PubMed ID: 8690764
[TBL] [Abstract][Full Text] [Related]
4. Treatment of acyclovir-resistant herpes simplex and varicella zoster virus infections.
Safrin S
Adv Exp Med Biol; 1996; 394():59-66. PubMed ID: 8815710
[No Abstract] [Full Text] [Related]
5. Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG.
Terry BJ; Mazina KE; Tuomari AV; Haffey ML; Hagen M; Feldman A; Slusarchyk WA; Young MG; Zahler R; Field AK
Antiviral Res; 1988 Dec; 10(4-5):235-51. PubMed ID: 2852486
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetic basis of oral valacyclovir treatment of herpes simplex virus (HSV) or varicella zoster virus (VZV) meningitis, meningoencephalitis or encephalitis in adults.
Cunha BA; Baron J
J Chemother; 2017 Apr; 29(2):122-125. PubMed ID: 26239190
[No Abstract] [Full Text] [Related]
7. Synthesis and antiherpes simplex virus activity of 9-[(1,3-dihydroxy-2-propylthio)methyl]guanine.
McGee DP; Martin JC; Smee DF; Matthews TR; Verheyden JP
J Med Chem; 1985 Sep; 28(9):1242-5. PubMed ID: 2993615
[TBL] [Abstract][Full Text] [Related]
8. Acyclovir - a review of the preclinical and early clinical data of a new antiherpes drug.
Brigden D; Fiddian P; Rosling AE; Ravenscroft T
Antiviral Res; 1981 Nov; 1(4):203-12. PubMed ID: 6280605
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of plaque formation of herpes simplex virus (HSV) and varicella-zoster virus (VZV) by subinhibitory dose of acyclovir (ACV).
Shiraki K; Miyaki C; Namazue J; Yamanishi K; Takahashi M
Acta Virol; 1989 Dec; 33(6):565-8. PubMed ID: 2576598
[TBL] [Abstract][Full Text] [Related]
10. Comparative anti-herpesvirus activities of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, acyclovir, and two 2'-fluoropyrimidine nucleosides.
Smee DF; Campbell NL; Matthews TR
Antiviral Res; 1985 Oct; 5(5):259-67. PubMed ID: 2998275
[TBL] [Abstract][Full Text] [Related]
11. Antiviral drugs for varicella-zoster virus and herpes simplex virus infections.
Med Lett Drugs Ther; 2018 Sep; 60(1556):153-157. PubMed ID: 30383727
[No Abstract] [Full Text] [Related]
12. Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus.
Earnshaw DL; Bacon TH; Darlison SJ; Edmonds K; Perkins RM; Vere Hodge RA
Antimicrob Agents Chemother; 1992 Dec; 36(12):2747-57. PubMed ID: 1336346
[TBL] [Abstract][Full Text] [Related]
13. The biochemistry and mechanism of action of acyclovir.
Elion GB
J Antimicrob Chemother; 1983 Sep; 12 Suppl B():9-17. PubMed ID: 6313600
[TBL] [Abstract][Full Text] [Related]
14. 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication.
Field AK; Davies ME; DeWitt C; Perry HC; Liou R; Germershausen J; Karkas JD; Ashton WT; Johnston DB; Tolman RL
Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4139-43. PubMed ID: 6306664
[TBL] [Abstract][Full Text] [Related]
15. [Contribution of the laboratory in case of resistance to acyclovir of herpes simplex and varicella zoster virus].
Morfin F; Frobert E; Thouvenot D
Ann Biol Clin (Paris); 2003; 61(1):33-40. PubMed ID: 12604384
[TBL] [Abstract][Full Text] [Related]
16. Comparative activity of penciclovir and acyclovir in mice infected intraperitoneally with herpes simplex virus type 1 SC16.
Sutton D; Boyd MR
Antimicrob Agents Chemother; 1993 Apr; 37(4):642-5. PubMed ID: 8388195
[TBL] [Abstract][Full Text] [Related]
17. Anti-herpesvirus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine.
Smee DF; Martin JC; Verheyden JP; Matthews TR
Antimicrob Agents Chemother; 1983 May; 23(5):676-82. PubMed ID: 6307132
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility of varicella-zoster virus to acyclovir.
Biron KK; Elion GB
Antimicrob Agents Chemother; 1980 Sep; 18(3):443-7. PubMed ID: 6252836
[TBL] [Abstract][Full Text] [Related]
19. [Antiviral resistance of herpes simplex virus and varicella-zoster virus].
Daikoku T; Shiraki K
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():480-6. PubMed ID: 17455667
[No Abstract] [Full Text] [Related]
20. Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections.
Balfour HH; Benson C; Braun J; Cassens B; Erice A; Friedman-Kien A; Klein T; Polsky B; Safrin S
J Acquir Immune Defic Syndr (1988); 1994 Mar; 7(3):254-60. PubMed ID: 8106965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
